Boyko S. Atanassov retweeted
Lab picnic 2023 with @mike_feigin @prasenjitdey @batanasoff
Boyko S. Atanassov retweeted
Excited to share our new publication spearheaded by talented PhD student Tao Dai, showing tumor cell adaptations regulated by PFKFB4 within hypoxic TME acquire metabolic and genetic plasticity driving #metastaticbreastcancer @RoswellPark cell.com/cell-reports/fullte…
Boyko S. Atanassov retweeted
Interested in heterochromatin and cancer? We have postdoc positions available in our lab at UW-Madison. Check out the opportunity… and our recent R01 score.
thelewislab.net/s/Postdoctor…
Boyko S. Atanassov retweeted
Often a major scientific discovery can be boiled down to a single plot in a paper. This is the birth of the field of epigenetic modification of chromatin by Brownell and Allis (now @RockefellerUniv) PMID: 7603997. Lane 2 is histone acetyltransferase (HAT) detected by... (1 of 3)
Boyko S. Atanassov retweeted
Our paper on highly specific inhibitors of the human SAGA deubiquitinating module/USP22 is out @CellChemBiol! Great work by @MikeyXtalsPhd, great collaboration with Hiroaki Suga and Tatsuya Ikenoue. authors.elsevier.com/a/1eHba…
Boyko S. Atanassov retweeted
Awesome fun at this year’s picnic with labs of @mikefeigin @prasenjitdey @batanasoff @subhamoy_d. Also welcoming the new PI #Hai Wang.
Boyko S. Atanassov retweeted
New publication from the Dasgupta lab spearheaded by talented graduate student @AbhishaSD and postdoc @MayrelPalestino in collaboration with Shawn Zhang Lab @lab_bcm and @LabZhu reveals a nuclear-mitochondrial communication signal in prostate cancer @RoswellPark @BCMFromtheLabs
Mitochondrial aconitase activity plays an important role in the development of advanced metastatic #ProstateCancer. Blocking SRC-2 to enhance SIRT3 expression may be a therapeutically valuable path, Dessai et al report.
@RoswellPark @LabZhu
https://xitter.gq/t.co/sgKlRGKzaW
Boyko S. Atanassov retweeted
happy to share our last ms online today @EpigenChromatin Ubp8, DUBm, @SAGA_Complex and the role of Spt7, we hope to have more news about Spt7 soon! Congrats @CarmeNuCab and Varinia and all authors We MUST celebrate this (virtual?) @IBV_CSIC @CSICval @SpringerNature @LoloMartin89
Boyko S. Atanassov retweeted
We are truly honored to receive @NIHDirector's New Innovator Award funded by @NIH_CommonFund. Credit goes to the talented people in my lab for their hard work and commitment to #NIHHighRisk science. Our lab @RoswellPark is expanding, interested students & postdocs please apply!
Read about how @subhamoy_d of @RoswellPark
will use a New Innovator Award from the #NIHHighRisk High-Reward Research program to study how proteins from the mitochondria may move to the cell nucleus and drive aggressive #cancer: https://xitter.gq/t.co/UfD6o1vpiM
Boyko S. Atanassov retweeted
I am honored and proud to share our contribution to the #SpecialIssue in #BBAGRM #inmemoryofSusanAbmayr. Sharon, @AimeeFarria, and I offer our unique perspective on Gcn5 and Pcaf in development and cancer. #mousemodels #development #cancer @SAGA_Complex
Boyko S. Atanassov retweeted
We are hiring a postdoc, who will work on immune-cancer cell crosstalk. Apply here. roswellpark.org/careers/post…
Boyko S. Atanassov retweeted
Structural basis for COMPASS recognition of an H2B-ubiquitinated nucleosome biorxiv.org/cgi/content/shor…
Boyko S. Atanassov retweeted
Placing USP22 at the centre of placenta vascularisation
A Research Highlight from our current issue, featuring @EKoutelou, Sharon Dent' & colleagues' SAGA complex paper
dev.biologists.org/content/1…
Boyko S. Atanassov retweeted
In a study published in @ScienceTM, our researchers report that a new anticancer agent has the potential to overcome treatment resistance in breast cancer. #bcsm @aaas goo.gl/c9LpEq
Boyko S. Atanassov retweeted
Now on-line in @CellCellPress : Mechanism of Cross-talk between H2B Ubiquitination and H3 Methylation by Dot1L. Awesome work by @WordenEvan , Nik Hoffmann and Chad Hicks. cell.com/cell/fulltext/S0092…
Boyko S. Atanassov retweeted
It's a great honor to be Chromatin Haikued! We're excited about our new work explaining how H2B - #ubiquitin activates H3K79 methylation by Dot1L - some real surprises. Also excited to report our first #cryoEM structures.
A histone fold twist
As Dot1L methylates
The nucleosome
#ChromatinHaiku #HistoneFold #H3K79 #H2Bub
biorxiv.org/content/early/20…




























